OCC — Orthocell Cashflow Statement
0.000.00%
- AU$149.74m
- AU$106.76m
- AU$16.23m
Annual cashflow statement for Orthocell, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.23 | 25.2 | 3.87 | 4.69 | 4.96 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.26 | 14.6 | -6.51 | -8.68 | -12.7 |
| Capital Expenditures | -0.535 | -0.632 | -0.942 | -0.359 | -1.27 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | -35.7 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.535 | -0.632 | -0.942 | -0.359 | -37 |
| Financing Cash Flow Items | — | — | -0.123 | -0.882 | -1.01 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.49 | -0.165 | 3.24 | 17 | 30.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.31 | 13.8 | -4.2 | 8.01 | -19.2 |